Back to search

Article

Silencing Of The DNA Damage Repair Regulator PPP1R15A Sensitizes Acute Myeloid Leukemia Cells To Chemotherapy

2024-01-31

Abstract excerpt

<title>Abstract</title> <p>Acute Myeloid Leukemia (AML) is a life-threatening disease whose induction treatment consists of combination chemotherapy with Idarubicin and Cytarabine for fit patients. Treatment failures are frequent, urging the need for novel treatments for this disease. The DNA Damage Response Mechanism (DDR) comprises numerous molecules and pathways intended to arrest the cell cycle until DNA dama...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
69ccfdc1-cf5b-5f7a-a9ac-88c62ac21422
DOI
10.21203/rs.3.rs-3891837/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Silencing Of The DNA Damage Repair Regulator PPP1R15A Sensitizes Acute Myeloid Leukemia Cells To ChemotherapyDOI 10.21203/rs.3.rs-3891837/v1
Select a neighboring publication to make it the new centre.